Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TKNO is expected to report earnings to rise 10.67% to -9 cents per share on August 06
Q2'25
Est.
$-0.10
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.01
Q3'24
Missed
by $0.04
Q2'24
Beat
by $0.03
The last earnings report on May 08 showed earnings per share of -9 cents, beating the estimate of -10 cents. With 249.03K shares outstanding, the current market capitalization sits at 108.10M.